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Introduction : Neuroinflammatory process and oxidative stress play an important role 
in the mechanism of brain aging and neurodegenerative diseases such as Alzheimer. 
Epigallocatechin-3-gallate (EGCG) have antioxidant, anti-inflammatory, and 
neuroprotective effects. This study aims to prove the effect of green tea EGCG on spatial 
memory function, malondialdehyde (MDA), and TNF-α level in Balb/c mice induced by D-
galactose. Method : An experimental study using ”post test only control group design”. The 
samples were 18 male Balb/c mices, aged 6-8 weeks, divided into 3 groups. Negative control 
group (N-C) was induced by subcutaneous injection of D-galactose (150 mg/kg) once daily 
for 6 weeks. EGCG-2 and EGCG-6 were induced by D-galactose and orally administered by 
2 and 6 mg/kg EGCG once daily for 5 weeks. The indicator of examination were spatial 
memory function using morris water maze, MDA and TNF-α level using Elisa. One-way 
Anova, Kruskal-Wallis, and Pearson were used for statistical analysis. Results : Means of 
% escape latency time and path length in the EGCG-2 {42,02(SD=5,9);43,47(SD=5,97)%} 
and EGCG-6 {40,45(SD=6,5); 41,78(SD=6,77)%} were significantly higher than N-C 
{28,68(SD=9,15), p=0,013; 32,98(SD=7,75)%,p=0,04}. MDA level in the EGCG-2 
{587,79(SD=76,04)ng/ml} was significantly smaller than N-C 
{722,64(SD=134,78)ng/ml,p=0,037}. TNF-α level in all groups was not different (p=0,786). 
There was a significant and strong correlation between MDA level and spatial memory 
function (r=-0.551; p=0,018). Conclusion : EGCG may improve spatial memory function 
and oxidative stress in mice induced dementia, but it may not improve the status of 
neuroinflammation. 
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Dementia has become a serious problem in 
the global health. The 2015 World Report 
Alzheimer's estimates that 46.8 million 
people worldwide are living with dementia in 
2015, with 9.9 million new cases each year 
(one new case every 3 seconds). This number 
is estimated will increase to 74.7 million 
cases by 2030 and 131.5 million by 2050. This 
estimation comes from a population-based 
study that examines the prevalence of 
dementia in different regions of the 
world1,28,33,34). According to The 2016 World 
Health Report, dementia contributed 11.2% 
causing disability cases in subjects aged over 
60 years, greater than stroke (9.5%), 
musculoskeletal disorders (8.9%), 
cardiovascular disease (5%), and all types of 
cancer (2.4%)33,34). 
Alzheimer's disease (AD) is the main cause 
of dementia (50-75%) in the elderly27). AD is 
a progressive and irreversible 
neurodegenerative disease, characterized by 
decreased of cognitive and memory function, 
and degeneration of cholinergic 
neurons3,12,15). Several studies have shown 
that oxidative stress and inflammatory 
process play an important role in the 
pathogenesis of brain aging and 
neurodegenerative diseases such as 
Alzheimer10,14,23,24,30).  
* Corresponding author: Ainun Rahmasari Gumay, Address: Faculty of Medicine Diponegoro University, 
Jl. Prof. Soedharto SH Tembalang Semarang, Central Java, Indonesia, Postal Code: 50275.  
Email: ainungumay@fk.undip.ac.id 
Hiroshima J. Med. Sci. 
Vol. 67, Special Issue, May, 2018  
42 
 
Oxidative stress is a condition 
characterized by an imbalance between pro-
oxidant molecules and the antioxidant 
system2). MDA is formed by the degradation 
of free radicals OH- from unsaturated fatty 
acids, converted to highly reactive free 
radicals2,14). In this study, MDA is examined 
because it is the final product of lipid 
peroxidation process that can represent 
oxidative stress processes in the central 
nervous system. 
Spatial memory is one of the important 
indicators for assessing neurocognitive 
function. Hippocampus is an important part 
of the brain in mediating spatial and 
contextual memory functions. Morris water 
maze (MWM) is a standardized examination 
used to assess the hippocampal-dependent 
memory in experimental animal. The MWM 
plays an important role in the validation of 
rodent models for neurocognitive disorders 
such as AD8,9,31).  
D-galactose are known to be widely used 
in animal model for brain aging and 
neurodegenerative diseases. D-galactose is 
known to cause aging-related changes 
including the spatial memory impairment 
and destruction of nerve cells. D-galactose 
causes cellular metabolic damage by 
decreasing the activity of Na+,K+,ATPase 
enzymes and increasing oxidative stress 
through increased lipid peroxidation and 
decreased antioxidant enzyme activity24).  
Several studies have shown that 
epigallocatechin-3-gallate (EGCG) is a major 
polyphenol in green tea that has antioxidant, 
anti-inflammatory, anticancer, and 
neuroprotective effects20-24). In a cross-
sectional study in Japan that examined the 
association between green tea consumption 
and cognitive function, it was mentioned that 
the consumption of green tea 2 cups or more 
per day (100 ml/ cups) was associated with a 
decreased prevalence of cognitive 
impairment19). However, in other study 
showed that the administration of EGCG 
with a dose of 50 mg/kgBW was not able to 
improve spatial memory function or repair 
brain nerve cells damage in repeated 
ischemic induced Balb/c mice29). The exact 
effect of EGCG on cognitive remains unclear. 
This study attempts to prove the effect of 
EGCG green tea on spatial memory function, 
oxidative stress, and neuroinflammatory 
status in D-galactose induced Balb/c mice. 
The use of multilevel doses is intended to 
obtain the most effective dose that can 
provide optimal results. 
 
MATERIALS AND METHODS 
Experimental animals and study design 
This research was an experimental study 
with randomized, post test only control group 
design. The samples were 18 Balb/c males 
mices, aged 6-8 weeks obtained from the 
Integrated Research and Testing Laboratory, 
Gajah Mada University, Jogjakarta, 
Indonesia. 
The sample was divided into 3 groups by 
simple randomization. N-C group was 
induced by subcutaneous injection of D-
galactose (150 mg/kg) once daily for 6 weeks. 
EGCG-2 and EGCG-6 were induced by D-
galactose and orally administered by 2 and 6 
mg/kgBW EGCG once daily for 5 weeks. The 
mean of mice body weight before treatment in 
N-C group was 29,60 (SD = 0,99) gram, 
EGCG-2 group was 27,87 (SD = 1,21) gram, 
and EGCG-6 group was 28.52 (SD = 0.75) 
gram, thus qualify the normality assumption 
(Shapiro Wilk p > 0.05) and homogenity 
(Lavene's test p = 0.412).  
 
Reagents and chemicals 
The pure epigallocatechin-3-gallate 
(EGCG) green tea compound was obtained 
from the Sigma-Aldrich with E-4143 catalog 
code, as well as the D-galactose reagent 
obtained from the Sigma-Aldrich with G-
0750 catalog code. 
 
Morris water maze test 
At the end of the 6th week of treatment 
and induction, spatial memory function was 
examined with morris water maze (MWM). 
The MWM is a circular pool filled with water 
(100 cm in diameter and 50 cm in height). 
Mices were trained to use extra-maze visual 
cues to locate an escape platform hidden just 
below the surface of the opaque water. In this 
procedure, the test was done through 3 
phases: (1) Learning/ acquisition phase: a 
training process for mices to form their 
spatial memory. Mice were trained to find a 
hidden platform. The platform was placed in 
± 1 cm below the surface of the water, in a 
predetermined quadrant. This phase was 
done for 4 days in a row with 4 times per day. 
Mice tested their ability to escape, 
characterized by the success of mice to find a 
hidden platform. The path length and escape 
latencies time to find the terminal platform 
for all mice in 6 days were measured and 
calculated;  (2) Retention phase (probe trial): 
a test phase of spatial memory function. This 




phase is carried out at least 24 hours after 
the last exercise in the acquisition phase, and 
made just 1 time. Platform removed, and the 
mice were given 60 seconds to locate the 
previous platform. The parameter 
measurement was % time and % distance in 
target quadrant; (3) Visual testing: to assess 
the sensorimotor and visual functions of the 
animals. Trial was done 3 times in 1 day. 
Mice were given 60 seconds per trial to find a 
visible platform. The path length and escape 
latencies were recorded8,9,31).  
 
Termination and preparation of sample 
After MWM examination, mice 
subsequently terminated by cervical 
dislocation techniques. The hippocampal 
dissection procedure was based on the 
protocol of previous studies by Beaudoin, et 
al, 20126).  
The mice hippocampal tissues were 
weighed and then homogenized together with 
phosphate buffered saline (PBS; pH 7.4) with 
a ratio of tissue weight and volume of PBS is 
1:9. Then homogeneous solution was 
centrifuged at 8000 rpm for 15 min at 4° C, 
thus obtained supernatant of hippocampal 
tissue. 
 
Measurement of malondialdehyde level 
The supernatants were used for 
measurements of MDA level using MDA 
assay kits (Elabscience, USA). Data was read 
at 450 nm wavelength and MDA levels were 
expressed as ng/ ml protein. 
 
Measurement of TNF-α level 
The supernatants were used for 
measurements of TNF-α level using TNF-α 
assay kits (BioLegend, LEGEND MAX, 
California USA). Cytokines in tissue were 
expressed as pg/ ml protein. 
 
Statistical analysis 
One-way Anova, Kruskal-Wallis, and 
Pearson were used for statistical analysis. 
Statistical analyses were done using SPSS 
version 21.0 for Windows. 
Ethical clearance 
The study protocol has received ethical 
approval from the Medical Research Ethics 
Committee of Faculty of Medicine, 
Diponegoro University/ Dr. Kariadi 
Semarang with ethical clearance no. 462 / EC 





The visual testing phase of MWM showed 
that all mice can reach the platform before 
the time runs out (<60 seconds). The slowest 
escape latency time was in the EGCG-2 group 
(6.49 (SD=3.85)) seconds, while the fastest 
was in the EGCG-6 group (6.21 (SD=4.42)) 
seconds. The longest path length was in the 
N-C group (0.92 (SD=0.25)) meters, while the 
shortest was in the EGCG-6 group (0.83 
(SD=0.41)) meters. The Kruskal-Wallis test 
showed that there was no differences 
between N-C, EGCG-2, and EGCG-6 group 
for escape latency time (p = 0.960) and path 
length (p = 0,587). This result showed that 
there was no difference of sensorimotor 
function of the mice in the N-C, EGCG-2, and 
EGCG-6 groups, so the acquisition trial and 
probe trial can be done. 
The learning phase (acquisition trial) of 
MWM showed that mice in the N-C group 
took longer time and longer distance to find 
hidden platform on day 1, 2, 3, or 4. Mice on 
EGCG-2 and EGCG groups showed better 
results with faster escape latency time 
recording and shorter path length when 
compared to the N-C group especially at days 
2, 3, and 4 (p <0.05). While between EGCG-2 
and EGCG-6 group, the results were not 
different from the first day until the fourth 
day (p> 0,05).  
In the probe trial phase it was found that 
the lowest % time was in the N-C group 
(28.68 (SD=9,15))%, while the highest was in 
the EGCG-2 group (42.02 (SD=5.90))%. The 
One Way Anova test showed a significant 
difference between the experimental groups 
(F = 5,593; p=0.015). The post hoc LSD test 
showed a significant difference between the 
N-C group and the EGCG-2 group (p = 0.007), 
and between the N-C group and the EGCG-6 
group (p = 0.014). But there was no difference 
between EGCG-2 and EGCG-6 group (p = 
0,716) (Figure 1). Mean of % path length in 
probe trial phase was lowest in the N-C group 
(32.98 (SD = 7.75))%, while the highest was 
in the EGCG-2 group (43.47 (SD = 5.97))%. 
One Way Anova test showed a significant 
differences between experimental groups (F = 
4.028, p = 0.040). The post hoc LSD test 
showed a significant difference between the 
N-C group and the EGCG-2 group (p = 0.018), 
and between the N-C group and the EGCG-6 
group (p = 0.042). But there was no differenc 
e between EGCG-2 and EGCG-6 (p = 0.677) 
(Figure 2). This result proves the hypothesis 
that EGCG in both 2 and 6 mg / kgBW doses 
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has an effect on the improvement of spatial 
memory function in dementia induced Balb/c 
mice using D-galactose. 
In this study it was found that the lowest 
MDA levels were in the EGCG-2 group 
(587.79 (SD = 76.04)) ng / ml, while the 
highest was in the N-C group (722.64 (SD = 
134.78)) ng/ ml. Kruskal-Wallis test showed 
no differences between experimental groups 
(p=0.141). The Mann-Whitney test showed a 
significant difference between the N-C and 
EGCG-2 groups (p=0.037). In contrast, no 
differences were found between the N-C and 
EGCG-6 groups (p=0.470), and between the 
EGCG-2 and EGCG-6 groups (p=0.336) 
(Figure 3). Thus, it can be concluded that 
EGCG 2 mg/ kgBW can affect decreased 
levels of dementia-induced hippocampus 
MDA mice. Pearson correlation test showed a 
significant correlation between MDA level 
and spatial memory function (p= 0,018; 
r=0,551). Negative correlation, indicating 
that higher MDA levels are associated with 
lower spatial memory function. The 
correlation diagrams of MDA level and 
spatial memory function are presented in 
Figure 4. 
In this study it was found that EGCG 
orally at a dose of 2 and 6 mg/kgBW daily for 
5 weeks did not provide changing levels of 
TNF-α (p=0.786). Pearson correlation test 
showed no correlation between TNF-α levels 



































Figure 2. Mean Comparison of % path length in target quadrant on probe trial phase mean (SD) 
 
 







































Figure 4. Correlation between MDA level (ng/ml) and spatial memory function 
 
DISCUSSION 
The result of this study indicate that mice 
in EGCG-2 and 6 group showed better ability 
with faster escape latency time recording and 
shorter distance compared to control in 
learning phase of MWM.  In addition, the 
mice in EGCG-2 and 6 group also showed 
better memory ability, with high percentage 
of time and path length in target quadrant 
compared with control group (p=0,015; 
p=0,040) in probe trial phase of MWM. This 
is in consistant with previous studies which 
stated that EGCG green tea can improve 
memory spatial function in experimental 
animals24). Other studies have suggested that 
administering EGCG 10 mg/kgBW daily for 4 
weeks can improve the cognitive abilities of 
Wistar rats induced dementia by 
intracerebroventrikular streptozotocin7). 
However, the results of this study did not 
match the previous study which states that 
the administration of EGCG with a dose of 50 
mg/kgBW is not able to increase spatial 
memory function or repair brain nerve cells 
damaged in repeated ischemic induced Balb/c 
mice29). These different results are likely due 
to different duration of EGCG 
administration. In the study by Pu et al, 
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EGCG was given only 2 times, ie 30 minutes 
before ischemic induction was done. This 
allows less optimum effects of EGCG to 
repair memory impairment due to ischemic 
induction. In this study, EGCG was 
administered in small doses for a relatively 
long time (5 weeks). This causes the 
accumulation of EGCG optimally and give 
better effect. 
Spatial memory is an important indicator 
in assessing neurocognitive function of an 
individual. Spatial memory impairment is 
often an early symptom found in early 
dementia. Dementia is a major cause of 
disability in elderly. In the aging process, 
Alzheimer's disease is the main cause (50-
75%) of dementia in the elderly27).  
The experimental animals induced by D-
galactose are known to be widely used in 
brain aging and neurodegenerative diseases. 
The results of this study indicate that mice in 
N-C group take longer time and longer 
distance to find hidden platform when 
compared with EGCG-2 and 6 group. Mice in 
the N-C group also get difficulties in recalling 
the location of the platform, indicated by the 
low percentage of time and path length 
passed in the target quadrant of MWM. This 
is consistent with previous studies in which 
150 mg/kgBW subcutaneous injections of D-
galactose daily for 6 weeks may cause 
behavioral and memory impairment in 
mice18,24,26). D-galactose is also known to 
cause spatial memory impairment and nerve 
cell damage due to cellular metabolic damage 
by decreasing the activity of Na+, K+, ATPase 
enzymes and increasing oxidative stress 
through increased lipid peroxidation and 
decreased antioxidant enzyme activity24). 
Hadzi-Petrushev et al mentioned that 
administration of D-galactose intragaster 
100 mg/kgBW for 6 weeks was able to 
increase levels of TNF-α and IL-1β plasma 
and lipid peroxidation. This study proves 
that administration of D-galactose at 
concentrations exceeding normal can lead to 
the production of free radicals and advanced 
glycation end products (AGEs). AGE will 
bind to its receptors (RAGE) and trigger 
activation of the nuclear factor-κB (NF-κB) 
transcription factor that plays a role in the 
production of proinflammatory cytokines 
(TNF-α and IL-1β) and free radicals16).    
Oxidative stress and inflammatory 
processes are known to play an important 
role in the pathogenesis of neurodegenerative 
diseases such as Alzheimer's 
disease10,14,17,23,24,30,32). Several studies have 
shown that epigallocatechin-3-gallate 
(EGCG), a major polyphenol in green tea, has 
antioxidant, anti-inflammatory, anticancer, 
and neuroprotective effects20-24). However, 
other studies suggest that EGCG or green tea 
extract with a certain dose does not have a 
significant effect on cognitive function, 
oxidative stress, or neuroinflammatory 
status13,29). Excess production of reactive 
oxygen species and or decreased activity of 
antioxidant enzymes in the brain can lead to 
lipid peroxidation processes, mitochondrial 
DNA damage, and protein oxidation, leading 
to impaired neurocognitive function24). 
Malondialdehyde (MDA) is a dialdehyde 
compound which is the final product of lipid 
peroxidation in the body2,14,17,25). D-galactose 
induction in experimental animals is known 
to cause impaired cognitive functioning 
because it triggers cellular oxidative stress, 
increases MDA levels, decreases SOD and 
GSH-Px enzyme activity11).  
The results of this study indicate that 
EGCG 2 and 6 mg/kgBW given daily for 5 
weeks can decrease MDA levels in D-
galactose-induced mice hippocampus. 
Pearson correlation test showed that there 
was a significant correlation between MDA 
level and spatial memory function (p=0.018), 
with strong correlation strength (r=0.551), 
and negative correlation direction indicating 
that higher MDA level was associated with 
lower spatial memory function. This is in 
consistant with previous studies that 
mention the antioxidant effects of EGCG on 
the central nervous system4,12,24). Ejaz Ahmed 
et.al proved that 10 and 20 mg/ kgBW of 
green tea catechin hydrate orally for 3 weeks 
was able to increase the activity of SOD, 
GSH-Px, and catalase enzymes, also decrease 
MDA level of hippocampus Wistar rats 
induced by intracerebroventricular 
streptozotocin12). Other studies have 
suggested that administration of green tea 
extract can significantly lower MDA levels 
when compared with controls4). However, 
these results differ from research of  Flores et 
al mention that green tea extracts containing 
EGCG 299.56 ug/ml administered over one 
month can not change hippocampus MDA 
levels in 10 months Wistar rats13). This 
difference is likely to be influenced by the age 
of the experimental animal, the duration of 
the intervention, the dose concentration, and 
the type of the experimental animal. 
In this study it was found that EGCG 2 
and 6 mg/kgBW did not provide changes in 
TNF-α levels. This is due to the use of young 




adult animals in this study. Older 
experimental animals show an exaggerated 
and more prolonged neuroinflammatory 
response when compared to young adults. In 
a study conducted by Barrientos et.al who 
studied the proportionate responses of 
proinflammatory cytokines in mice (3 
months) and old age (24 months) infected 
with Escherichia coli, it was found that both 
groups had an elevated IL -1β hippocampus 
at 2 h post infection. IL-1β levels in mouse 
hippocampus decreased significantly after 24 
h post-infection in adult rats group, whereas 
in old age rats group IL-1β levels continued 
to increase until the 8th day post infection. IL-
1β levels decreased as baseline after the 14th 
post infection day. This suggests a more 
durable neuroinflammatory response to the 
aging process.5) In this study, researchers 
used young adult rats (6-8 weeks) in which 
new TNF-α levels were tested on the 7th day 
after the last D-galactose injection. This 
allows the decrease of TNF-α levels to initial 
conditions. This became one of the limitations 
in this study. Further research on the effects 
of green tea EGCG on neuroinflammatory 
status should be performed using effective 
timing of TNF-α assay levels post-dementia 
induction. 
From this research we can conclude that 
EGCG may improve spatial memory function 
and oxidative stress in mice induced 
dementia, but it may not improve the status 
of neuroinflammation.  
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